Compagnie du Bois Sauvage S.A.

DB:C5S Stock Report

Market Cap: €360.4m

Compagnie du Bois Sauvage Valuation

Is C5S undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of C5S when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: C5S (€215) is trading below our estimate of fair value (€708.8)

Significantly Below Fair Value: C5S is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for C5S?

Key metric: As C5S is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for C5S. This is calculated by dividing C5S's market cap by their current revenue.
What is C5S's PS Ratio?
PS Ratio1.2x
Sales€297.02m
Market Cap€360.42m

Price to Sales Ratio vs Peers

How does C5S's PS Ratio compare to its peers?

The above table shows the PS ratio for C5S vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average4.7x
CHG CHAPTERS Group
6x20.2%€524.2m
PZS Scherzer
9.8x10.0%€65.3m
GLJ Grenke
1.3x14.1%€705.1m
JDC JDC Group
1.5x11.2%€313.7m
C5S Compagnie du Bois Sauvage
1.2xn/a€360.4m

Price-To-Sales vs Peers: C5S is good value based on its Price-To-Sales Ratio (1.2x) compared to the peer average (4.7x).


Price to Sales Ratio vs Industry

How does C5S's PS Ratio compare vs other companies in the DE Diversified Financial Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
EBEN aifinyo
0.3xn/aUS$15.51m
EBEN aifinyo
0.2xn/aUS$13.92m
CSQ creditshelf
0.005xn/aUS$29.25k
No more companies available in this PS range
C5S 1.2xIndustry Avg. 2.0xNo. of Companies3PS01.22.43.64.86+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: C5S is good value based on its Price-To-Sales Ratio (1.2x) compared to the European Diversified Financial industry average (2x).


Price to Sales Ratio vs Fair Ratio

What is C5S's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

C5S PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.2x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate C5S's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst C5S forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€215.00
€332.50
+54.7%
6.8%€355.00€310.00n/a2
Nov ’25€238.00
€332.50
+39.7%
6.8%€355.00€310.00n/a2
Oct ’25€254.00
€332.50
+30.9%
6.8%€355.00€310.00n/a2
Sep ’25€269.00
€336.50
+25.1%
7.9%€363.00€310.00n/a2
Aug ’25€271.00
€336.50
+24.2%
7.9%€363.00€310.00n/a2
Jul ’25€247.00
€336.50
+36.2%
7.9%€363.00€310.00n/a2
Jun ’25€271.00
€326.50
+20.5%
5.1%€343.00€310.00n/a2
May ’25€256.00
€326.50
+27.5%
5.1%€343.00€310.00n/a2
Apr ’25€245.00
€326.50
+33.3%
5.1%€343.00€310.00n/a2
Mar ’25€250.00
€341.50
+36.6%
0.4%€343.00€340.00n/a2
Feb ’25€271.00
€341.50
+26.0%
0.4%€343.00€340.00n/a2
Jan ’25€280.00
€341.50
+22.0%
0.4%€343.00€340.00n/a2
Dec ’24€265.00
€341.50
+28.9%
0.4%€343.00€340.00n/a2
Nov ’24€261.00
€341.50
+30.8%
0.4%€343.00€340.00€238.002
Oct ’24€272.00
€341.50
+25.6%
0.4%€343.00€340.00€254.002

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies